NASDAQ:CASM - CAS Medical Systems Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$1.9423 -0.05 (-2.51 %)
(As of 01/20/2019 04:00 PM ET)
Previous Close$1.9423
Today's Range$1.94 - $2.01
52-Week Range$0.99 - $2.70
Volume28,191 shs
Average Volume35,648 shs
Market Capitalization$56.05 million
P/E Ratio-7.19
Dividend YieldN/A
Beta0.16
CAS Medical Systems, Inc., a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. The company provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories, as well as offers FORE-SIGHT ELITE monitors. Its FORE-SIGHT absolute tissue oximeter provides non-invasive and quantitative measurement of oxygenation for cerebral tissue during surgery or critical care situations. The company also offers repair services for parts. It markets products through its own sales force, distributors, and manufacturers' representatives, as well as through hospitals, surgery centers, and outpatient facilities. CAS Medical Systems, Inc. was founded in 1984 and is headquartered in Branford, Connecticut.

Receive CASM News and Ratings via Email

Sign-up to receive the latest news and ratings for CASM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CASM
CUSIPN/A
Phone203-488-6056

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$18.76 million
Book Value($0.40) per share

Profitability

Net Income$-2,330,000.00

Miscellaneous

Employees76
Market Cap$56.05 million
OptionableNot Optionable

CAS Medical Systems (NASDAQ:CASM) Frequently Asked Questions

What is CAS Medical Systems' stock symbol?

CAS Medical Systems trades on the NASDAQ under the ticker symbol "CASM."

How were CAS Medical Systems' earnings last quarter?

CAS Medical Systems Inc (NASDAQ:CASM) issued its quarterly earnings results on Wednesday, October, 31st. The medical technology company reported ($0.06) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.07) by $0.01. The medical technology company had revenue of $5.38 million for the quarter, compared to analysts' expectations of $5.23 million. View CAS Medical Systems' Earnings History.

When is CAS Medical Systems' next earnings date?

CAS Medical Systems is scheduled to release their next quarterly earnings announcement on Wednesday, March 13th 2019. View Earnings Estimates for CAS Medical Systems.

Has CAS Medical Systems been receiving favorable news coverage?

News stories about CASM stock have been trending neutral this week, according to InfoTrie Sentiment. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. CAS Medical Systems earned a media sentiment score of 0.1 on InfoTrie's scale. They also gave news stories about the medical technology company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Who are some of CAS Medical Systems' key competitors?

Who are CAS Medical Systems' key executives?

CAS Medical Systems' management team includes the folowing people:
  • Mr. Thomas M. Patton, Pres, CEO & Director (Age 55)
  • Mr. Jeffery A. Baird, CFO & Sec. (Age 65)
  • Mr. John K. Gamelin, VP of R&D (Age 54)
  • Dr. Paul B. Benni, Chief Scientific Officer (Age 51)
  • Susan Carron, Director of Corp. Communications

Who are CAS Medical Systems' major shareholders?

CAS Medical Systems' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Douglas Lane & Associates LLC (0.12%). Company insiders that own CAS Medical Systems stock include James E Flynn and John Gamelin. View Institutional Ownership Trends for CAS Medical Systems.

Which major investors are buying CAS Medical Systems stock?

CASM stock was bought by a variety of institutional investors in the last quarter, including Douglas Lane & Associates LLC. View Insider Buying and Selling for CAS Medical Systems.

How do I buy shares of CAS Medical Systems?

Shares of CASM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CAS Medical Systems' stock price today?

One share of CASM stock can currently be purchased for approximately $1.9423.

How big of a company is CAS Medical Systems?

CAS Medical Systems has a market capitalization of $56.05 million and generates $18.76 million in revenue each year. The medical technology company earns $-2,330,000.00 in net income (profit) each year or ($0.27) on an earnings per share basis. CAS Medical Systems employs 76 workers across the globe.

What is CAS Medical Systems' official website?

The official website for CAS Medical Systems is http://www.casmed.com.

How can I contact CAS Medical Systems?

CAS Medical Systems' mailing address is 44 East Industrial Road, Branford CT, 06405. The medical technology company can be reached via phone at 203-488-6056 or via email at [email protected]


MarketBeat Community Rating for CAS Medical Systems (NASDAQ CASM)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  112 (Vote Outperform)
Underperform Votes:  112 (Vote Underperform)
Total Votes:  224
MarketBeat's community ratings are surveys of what our community members think about CAS Medical Systems and other stocks. Vote "Outperform" if you believe CASM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CASM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2019 by MarketBeat.com Staff

Featured Article: What is the quiet period?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel